Holen Sie sich die Stockscreener-App
6.80
7.77%
0.49
Handel nachbörslich:
6.81
0.010
+0.15%
Nyxoah Sa Aktie (NYXH) Neueste Nachrichten
What drives Nyxoah SA’s stock priceQuarterly Trade Report & Verified Short-Term Plans - mustnews.co.kr
Nyxoah SA Uptrend in Early Stages Indicators Say YesWeekly Profit Recap & Real-Time Volume Triggers - newsyoung.net
What’s the recovery path for long term holders of Nyxoah SAQuarterly Profit Review & AI Based Buy and Sell Signals - Newser
Top chart patterns to watch in Nyxoah SAEarnings Risk Report & Detailed Earnings Play Alerts - Newser
Nyxoah SA stock momentum explainedTrade Analysis Summary & Daily Profit Focused Stock Screening - Newser
Will Nyxoah SA benefit from macro trends2025 Fundamental Recap & Fast Gain Swing Trade Alerts - Newser
Nyxoah sees Q2 revenue up 73%, plans R&D shift to U.S. and Belgium; shares rise - MSN
Nyxoah wins FDA approval for Genio OSA treatment - BioWorld MedTech
Nyxoah Gains FDA Approval for Genio System, Reports 73% Revenue Increase in Q2 2025. - AInvest
Nyxoah shares rise 8.12% premarket after FDA approval for Genio system. - AInvest
What recovery options are there for Nyxoah SADaily Equity Signal Strength Summary Report - Newser
Nyxoah SA's (EBR:NYXH) market cap up €31m last week, benefiting both retail investors who own 30% as well as insiders - simplywall.st
Statistical indicators supporting Nyxoah SA’s strengthFree Low Risk Swing Trade Opportunity List - Newser
Smart tools for monitoring Nyxoah SA’s price actionPredictive Analytics for Equity Growth Potential - Newser
Stifel Maintains Nyxoah SA(NYXH.US) With Buy Rating - 富途牛牛
FDA Approves Bilateral Neurostimulator for Subset of OSA Patients - Sleep Review
Nyxoah stock surges after FDA approves Genio system for sleep apnea - Investing.com India
Nyxoah revenue jumps 73% to €1.3M in Q2 2025 - Medical Buyer
Cantor Fitzgerald reiterates Overweight rating on Nyxoah stock following FDA approval - Investing.com Nigeria
Visualizing Nyxoah SA stock with heatmapsFree Community Verified Stock Suggestions - Newser
Nyxoah reports preliminary Q2 revenue EUR 1.3M - TipRanks
Nyxoah's FDA Approval and Strategic Shifts: A High-Risk, High-Reward Play in the OSA Market? - AInvest
Nyxoah Q2 Revenue Rises 73%, Shifts R&D to US and Belgium; Shares Surge - AInvest
Real time social sentiment graph for Nyxoah SABuy Alert Based on RSI and Volume - Newser
Nyxoah SA Trading Near Value Zone — Recovery AheadMarket Surge Signal for Swing Traders Triggered - beatles.ru
Nyxoah Reports Preliminary Q2 2025 Results, FDA Approves Genio System for Moderate to Severe Sleep Apnea Patients - AInvest
FDA Approves Nyxoah's Revolutionary Sleep Apnea Device While Inspire Launches Patent Battle - Stock Titan
How Nyxoah SA stock performs during market volatilityFree Quick Gain Stock Watch With Indicators - Newser
Nyxoah Announces Preliminary Results for the Second Quarter of 2025 - Informazione.it
What are the future prospects of Nyxoah SATrade Picks with 3x Upside - thegnnews.com
Nyxoah Receives Approval from FDA for Genio® System for the Treatment of Obstructive Sleep Apnea - TradingView
FDA Approval: New Genio Sleep Apnea Device Shows 71% Success Rate in Clinical Trials - Stock Titan
When is the best time to buy Nyxoah SA stockFree Opportunity Map for Daily Stock Trading - Newser
Is Nyxoah SA forming a reversal patternHigh Reward Picks with Tight Risk Control - Newser
What drives Nyxoah SA stock priceOverwhelming financial success - Jammu Links News
Is it the right time to buy Nyxoah SA stockStay ahead with daily market updates - Jammu Links News
How does Nyxoah SA generate profit in a changing economyFree Stock Market Query - Jammu Links News
Does Nyxoah SA stock perform well during market downturnsHigh-profit stock alerts - Jammu Links News
What are the latest earnings results for Nyxoah SAFree Daily Trading Room Entry - Jammu Links News
How volatile is Nyxoah SA stock compared to the marketAchieve breakthrough performance with smart picks - Jammu Links News
What is the risk reward ratio of investing in Nyxoah SA stockFree Predictions - Jammu Links News
What markets is Nyxoah SA expanding into Is HTOOW stock a good long term investment optionExplosive returns - Jammu Links News
When is Nyxoah SA stock expected to show significant growthStrongest growth potential - Jammu Links News
Is Nyxoah SA stock overvalued or undervaluedMassive stock growth - Jammu Links News
1.96%
1.41%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):